TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study

NACompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

January 21, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

September 17, 2021

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DEVICE

TactiCath Quartz treatment

Trial Locations (20)

10029

Mount Sinai Hospital, New York

11794

Stony Brook University Medical Center, Stony Brook

19104

Hospital of the University of Pennsylvania, Philadelphia

22908

University of Virginia Medical Center, Charlottesville

29425

Medical University of South Carolina, Charleston

30322

Emory University Hospital, Atlanta

37203

Centennial Medical Center, Nashville

39216

Jackson Heart Clinic, Jackson

40202

University of Louisville, Louisville

44195

The Cleveland Clinic Foundation, Cleveland

48075

Providence Hospital, Southfield

48532

Cardiology Consultants of East Michigan, Flint

66160

Kansas University Medical Center, Kansas City

77030

The Methodist Hospital, Houston

78704

Texas Cardiac Arrhythmia, Austin

91204

Glendale Memorial Hospital and Health Center, Glendale

95819

Regional Cardiology Associates, Sacramento

97225

Providence Heart and Vascular Institute, Portland

02114

Massachusetts General Hospital, Boston

02115

Brigham and Womens Hospital, Boston

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY